Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,194 INR | -1.30% | +2.91% | +39.84% |
May. 30 | Transcript : Glenmark Pharmaceuticals Limited - Analyst/Investor Day | |
May. 29 | Assertio Therapeutics Names Brendan O'Grady as Chief Executive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.84% | 4.04B | |
+19.64% | 43.3B | |
+21.25% | 22.22B | |
+18.92% | 15.43B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals Swings to Loss in Fiscal Q2; Shares Slide 5%